Nesta página
01AORT preço
02Instantâneo
03Gráfico
04Divisões de Ações
05Sobre
06Desempenho
07Avaliação e rácios
13Dividendos
14Lucros
15Fundamentos Completos
16Demonstrações
17Investidores institucionais (13F)
18Ativistas e proprietários de 5%+
19Executivos da empresa
20Participação em ETFs
21Consenso
22Pares
23Notícias
26Minhas Métricas
AORT Artivion, Inc. Common Stock
NYSE · Health Care · Ver em SEC EDGAR ↗ fechar Out 2, 2026 10-K/10-Q Ago 7, 2026
$22,31
· % da faixa de 52 semanas
· acima do mínimo
· para alta
$19,16mínima 52 sem
$48,25máxima 52 sem
Capitalização de Mercado (MRQ)
$1.12B
P/E (TTM)
-371.8
EPS (TTM)
$-0.06
Receita (TTM)
$471M
seus distintivos
Intervalo 52 Semanas
$19–$48
Classificação do Analista
BUY
Preço-Alvo
$42
P/E
-371.8
ROE
-0.73%
Margem de Lucro Líquido
-0.67%
Sua barra de distintivos está vazia — fixe uma métrica em qualquer lugar desta página.
AORT Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$22.31
Capitalização de Mercado (MRQ)
$1.12B
P/E (TTM)
-371.8
EPS (TTM)
$-0.06
Receita (TTM)
$471M
ROE (TTM)
-0.73%
Dívida/Capital (MRQ)
0.8
Intervalo 52 Semanas
$19–$48
AORT Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
intervalo
barras
A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.
Divisões de Ações
| Data ex | Desdobramento | Tipo |
|---|---|---|
| 28 de Dezembro de 2000 | 3-for-2 | Para frente |
| 1 de Julho de 1996 | 2-for-1 | Para frente |
Sobre Artivion, Inc. Common Stock Visão geral da empresa da Wikipedia
Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.
## History
Artivion was founded as CryoLife in Sarasota, Florida in 1984 by Steven Anderson and Robert McNally. Anderson acted as the company’s president and CEO from its founding. The company later moved from Sarasota to the Atlanta metropolitan area. In January 2022 the company changed its name to Artivion, Inc.
In 2000, CryoLife began offering a surgical adhesive called BioGlue used for sealing surgical lacerations under high pressure, such as in arteries.
In February 2008, the FDA gave CryoLife approval for a new kind of heart valve, made from human tissues, which was the first to remove cells from the transplant tissue as opposed to only cleaning the tissue. In giving the approval, the FDA said the new valve, called the CryoValve SynerGraft Pulmonary Valve, had less of a chance of rejection than previous valves.
In 2010, CryoLife acquired the rights to manufacture and distribute PerClot, an absorbable hemostatic powder used in surgery.
In January 2016, the company acquired On-X Life Technologies and its principal product, a mechanical heart valve called the On-X aortic valve replacement, for $130 million.
In October 2017, Artivion acquired JOTEC GmbH, a German-based developer of medical devices for aortic and peripheral vascular diseases, for €225 million. In September 2020, the company acquired Ascyrus Medical.
In 2021, the company received FDA premarket application approval of its PerClot absorbable hemostatic system, which comprised PerClot granules and a delivery system for surgical use. Baxter International agreed to buy PerClot from Artivion in 2021. In 2023, after final FDA approval of the product, the purchase was completed.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
setorHealth Care
indústriaHealth Care
funcionários1.800
paísUS
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita$441M2016-12-31 → 2025-12-31
EPS$0.212016-12-31 → 2025-12-31
Fluxo de caixa livre$839.0K2016-12-31 → 2025-12-31
Margem líquida-0.67%2016-12-31 → 2025-12-31
Avaliação e Proporções
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
| Métrica | Tendência de 5 anos | AORT | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| P/E (TTM) | -371.8média 5A ≈5.0 | ≈5.0 | · | · | |
| P/S (TTM) | 2.4média 5A ≈3.0 | ≈3.0 | 3.9 | Subvalorizado | |
| P/B (MRQ) | 2.5média 5A ≈3.4 | ≈3.4 | 3.9 | Subvalorizado | |
| EV / EBITDA | 22.5média 5A ≈32.6 | ≈32.6 | · | · | |
| Preço / FCF (TTM) | -122.3média 5A ≈554.3 | ≈554.3 | · | · | |
| Preço / Fluxo de Caixa (TTM) | 26.8média 5A ≈-54.3 | ≈-54.3 | 38.0 | Sobreavaliado | |
| EV / Revenue (EV / Receita) | 2.9média 5A ≈3.7 | ≈3.7 | · | · | |
| EV / FCF | 1508.1média 5A ≈592.1 | ≈592.1 | · | · | |
| Preço / Valor Patrimonial Tangível (MRQ) | 3.8 | · | · | · |
A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
| Métrica | Tendência de 5 anos | AORT | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Margem Bruta (TTM) | 64.4%média 5A ≈64.8% | ≈64.8% | 64.0% | Em linha | |
| Margem Operacional (TTM) | 4.4%média 5A ≈4.8% | ≈4.8% | -7.6% | Em linha | |
| Margem EBITDA (TTM) | 9.6%média 5A ≈11.4% | ≈11.4% | -7.6% | Em linha | |
| Margem de Impostos Pré-Tributação (TTM) | 0.47%média 5A ≈-2.9% | ≈-2.9% | -8.7% | Em linha | |
| Margem de Lucro Líquido (TTM) | -0.67%média 5A ≈-4.2% | ≈-4.2% | -9.5% | Em linha | |
| ROA (TTM) | -0.33%média 5A ≈-1.8% | ≈-1.8% | -20.2% | Primeira linha | |
| ROE (TTM) | -0.73%média 5A ≈-5.1% | ≈-5.1% | -25.1% | Primeira linha | |
| ROIC | 3.4%média 5A ≈3.8% | ≈3.8% | -31.3% | Primeira linha |
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
| Métrica | Tendência de 5 anos | AORT | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido (MRQ) | 0.8média 5A ≈1.0 | ≈1.0 | 0.6 | Dívida alta | |
| Índice de liquidez corrente (MRQ) | 3.5média 5A ≈4.6 | ≈4.6 | 5.6 | Baixa liquidez | |
| Quick Ratio (Índice de Liquidez Seca) | 1.5média 5A ≈2.0 | ≈2.0 | 3.6 | Baixa liquidez | |
| Dívida de Longo Prazo / Patrimônio Líquido (MRQ) | 0.8média 5A ≈1.0 | ≈1.0 | 0.6 | Dívida alta |
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
| Métrica | Tendência de 5 anos | AORT | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Revenue YoY (Receita Ano a Ano) | 13.6%média 5A ≈11.8% | ≈11.8% | · | · | |
| Revenue CAGR 3Y (CAGR Receita 3A) | 12.0%média 5A ≈11.0% | ≈11.0% | · | · | |
| Revenue CAGR 5Y (CAGR Receita 5A) | 11.8% | · | · | · |
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
| Métrica | Tendência de 5 anos | AORT | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Asset Turnover (Giro do Ativo) | 0.5média 5A ≈0.5 | ≈0.5 | 0.5 | Em linha | |
| Inventory Turnover (Giro de Estoque) | 1.8média 5A ≈1.6 | ≈1.6 | 1.8 | Em linha | |
| Receivables Turnover (Giro de Contas a Receber) | 5.2média 5A ≈5.4 | ≈5.4 | 6.9 | Fraco | |
| Revenue / Employee (Receita anual ÷ funcionários (número de funcionários reportado, yfinance). Derivado — não é um conceito SEC-XBRL armazenado.) | ≈$245.2K | · | · | · |
valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana
Dividendos Rendimento, índice de pagamento, histórico de dividendos, CAGR de 5 anos
Pagamento Anualizado≈$0.12
| Data ex | Valor | Moeda | Rendimento |
|---|---|---|---|
| Dez 9, 2015 | $0,03 | USD | ≈1.2% |
| Set 9, 2015 | $0,03 | USD | ≈1.2% |
| Jun 10, 2015 | $0,03 | USD | ≈1.1% |
| Mar 11, 2015 | $0,03 | USD | ≈1.2% |
| Dez 10, 2014 | $0,03 | USD | ≈1.1% |
| Set 10, 2014 | $0,03 | USD | ≈1.2% |
| Jun 11, 2014 | $0,03 | USD | ≈1.3% |
| Mar 12, 2014 | $0,03 | USD | ≈1.2% |
| Dez 11, 2013 | $0,03 | USD | ≈1.1% |
| Set 11, 2013 | $0,03 | USD | ≈1.7% |
| Jun 12, 2013 | $0,03 | USD | ≈1.7% |
| Mar 12, 2013 | $0,03 | USD | ≈1.2% |
| Dez 12, 2012 | $0,03 | USD | ≈0.83% |
| Set 12, 2012 | $0,03 | USD | ≈0.45% |
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
-518.1%
Próximo relatório
Nov 04, 2026
| Período | Relatório | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|---|
| 30 de Junho de 2026 | Ago 5, 2026 | $-0.28 | $0.01 | -2845.1% |
| 31 de Março de 2026 | $0.03 | $0.05 | -40.1% | |
| 31 de Dezembro de 2025 | $0.05 | $0.08 | -40.0% | |
| 30 de Setembro de 2025 | $0.06 | $0.02 | 242.9% | |
| 30 de Junho de 2025 | $0.08 | $-0.00 | — | |
| 31 de Março de 2025 | $-0.01 | $-0.12 | 91.7% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $441M | $389M | $354M | $314M | $299M | $253M | $276M | $263M | $190M | $180M | $146M | $145M | |
| Cost of Revenue | $157M | $140M | $125M | $111M | $101M | $85M | $93M | $90M | $61M | $61M | $55M | $53M | |
| Gross Profit | $284M | $249M | $229M | $203M | $198M | $168M | $183M | $173M | $129M | $119M | $91M | $91M | |
| R&D Expense | $31M | $28M | $29M | $39M | $36M | $24M | $23M | $23M | $19M | $13M | $10M | $9M | |
| SG&A Expense | $226M | $181M | $209M | $157M | $170M | $141M | $143M | $141M | $101M | $92M | $75M | $74M | |
| Operating Expenses | $257M | $210M | $238M | $196M | $205M | $165M | $166M | $164M | $121M | $105M | $85M | $82M | |
| Operating Income | $34M | $39M | $6M | $6M | $8M | $2M | $17M | $9M | $8M | $22M | $5M | $9M | |
| Interest Expense | · | · | $25M | $18M | $17M | $17M | $15M | $16M | $5M | $3M | $62.0K | $175.0K | |
| Interest Income | $763.0K | $1M | $1M | $147.0K | $79.0K | $217.0K | $738.0K | $226.0K | $212.0K | $72.0K | $45.0K | $50.0K | |
| Other Non-op | $10M | $-10M | $-3M | $-3M | $-6M | $-3M | $-1M | $-141.0K | $260.0K | $-437.0K | $-484.0K | $-540.0K | |
| Pretax Income | $15M | $-8M | $-22M | $-15M | $-15M | $-17M | $2M | $-6M | $4M | $18M | $6M | $9M | |
| Income Tax | $5M | $6M | $9M | $4M | $7.0K | $-492.0K | $-76.0K | $-4M | $-143.0K | $8M | $2M | $1M | |
| Net Income | $10M | $-13M | $-31M | $-19M | $-15M | $-17M | $2M | $-3M | $4M | $11M | $4M | $7M | |
| EPS (Basic) | $0.22 | $-0.32 | $-0.75 | $-0.48 | $-0.38 | $-0.44 | $0.05 | $-0.08 | $0.11 | $0.33 | $0.14 | $0.26 | |
| EPS (Diluted) | $0.21 | $-0.32 | $-0.75 | $-0.48 | $-0.38 | $-0.44 | $0.05 | $-0.08 | $0.11 | $0.32 | $0.14 | $0.25 | |
| Shares (Basic) | 45,335,000 | 41,676,000 | 40,743,000 | 40,032,000 | 38,983,000 | 37,861,000 | 37,118,000 | 36,412,000 | 33,008,000 | 31,855,000 | 27,744,000 | 27,379,000 | |
| Shares (Diluted) | 47,162,000 | 41,676,000 | 40,743,000 | 40,032,000 | 38,983,000 | 37,861,000 | 37,860,000 | 36,412,000 | 34,163,000 | 32,822,000 | 28,542,000 | 28,313,000 | |
| EBITDA | $56M | $63M | $29M | $29M | $32M | $23M | $35M | $27M | $18M | $30M | · | $15M |
Balanço Patrimonial
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $65M | $53M | $59M | $39M | $55M | $61M | $34M | $41M | $40M | $57M | $38M | $33M | |
| Receivables | $90M | $79M | $72M | $62M | $53M | $46M | $53M | $47M | $48M | $28M | $23M | $21M | |
| Inventory | $92M | $80M | $82M | $74M | $77M | $73M | $53M | $45M | $47M | $26M | $15M | $13M | |
| Prepaid Expense | $43M | $19M | $16M | $18M | $15M | $14M | $12M | $7M | $5M | $3M | $5M | $5M | |
| Current Assets | $358M | $290M | $281M | $247M | $248M | $235M | $187M | $179M | $179M | $147M | $110M | $106M | |
| PP&E (Net) | $65M | $36M | $38M | $39M | $38M | $33M | $32M | $31M | $34M | $19M | $11M | $12M | |
| PP&E (Gross) | · | · | · | $127M | $120M | $111M | $103M | $96M | $93M | $74M | $64M | $62M | |
| Accum. Depreciation | · | · | · | $88M | $82M | $78M | $71M | $65M | $60M | $55M | $53M | $50M | |
| Goodwill | $254M | $241M | $247M | $244M | $250M | $260M | $187M | $189M | $188M | $78M | $11M | $11M | |
| Intangibles | $124M | $128M | $143M | $151M | $167M | $186M | $115M | $118M | $130M | $1M | $1M | $2M | |
| Other Non-current Assets | $15M | $24M | $9M | $7M | $8M | $15M | $14M | $8M | $7M | $2M | $6M | $5M | |
| Total Assets | $885M | $789M | $792M | $763M | $793M | $789M | $606M | $571M | $590M | $316M | $181M | $176M | |
| Accounts Payable | $16M | $18M | $13M | $12M | $10M | $10M | $10M | $8M | $10M | $6M | $5M | $4M | |
| Accrued Liabilities | $16M | $12M | $10M | $12M | $8M | $7M | $7M | $7M | $12M | $5M | $3M | $3M | |
| Current Liabilities | $102M | $67M | $58M | $50M | $45M | $60M | $45M | $35M | $43M | $30M | $20M | $21M | |
| Capital Leases | $34M | $40M | $44M | $41M | $45M | $14M | $18M | $0 | $7M | $11.0K | · | · | |
| Deferred Tax | $24M | $20M | $22M | $24M | $29M | $35M | $26M | $27M | $30M | $7.0K | · | · | |
| Other Non-current Liabilities | $9M | $8M | $7M | $7M | $6M | $7M | $7M | $7M | $8M | $5M | $3M | $3M | |
| Total Liabilities | $437M | $513M | $511M | $478M | $492M | $461M | $320M | $296M | $313M | $107M | $26M | $27M | |
| Long-term Debt | $215M | $314M | $307M | $308M | $309M | $292M | $216M | $217M | $219M | $72M | · | · | |
| Total Debt | $215M | $314M | $307M | $308M | $309M | $292M | $216M | $217M | $219M | $72M | · | · | |
| Common Stock | $493.0K | $434.0K | $426.0K | $418.0K | $414.0K | $404.0K | $390.0K | $385.0K | $376.0K | $342.0K | $298.0K | $292.0K | |
| Retained Earnings | $-51M | $-61M | $-48M | $-17M | $2M | $20M | $37M | $35M | $38M | $34M | $23M | $23M | |
| Treasury Stock | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $13M | $12M | $11M | $9M | |
| AOCI | $-3M | $-25M | $-12M | $-22M | $-10M | $7M | $-9M | $-6M | $2M | $-429.0K | $-76.0K | $-121.0K | |
| Stockholders' Equity | $448M | $276M | $282M | $284M | $301M | $329M | $286M | $275M | $277M | $209M | $155M | $149M | |
| Liabilities + Equity | $885M | $789M | $792M | $763M | $793M | $789M | $606M | $571M | $590M | $316M | $181M | $176M | |
| Shares Outstanding | 49,330,000 | 43,432,000 | 42,569,000 | 41,830,000 | 41,397,000 | 40,394,000 | 39,018,000 | 38,463,000 | 37,618,000 | 34,230,000 | 29,766,000 | 29,229,000 |
Fluxo de Caixa
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $22M | $24M | $23M | $22M | $24M | $21M | $18M | $18M | $10M | $8M | $6M | $6M | |
| Stock-based Comp | $24M | $14M | $14M | $12M | $11M | $7M | $9M | $6M | $7M | $6M | $5M | $3M | |
| Deferred Tax | $37.0K | $-2M | $-1M | $-885.0K | $-6M | $816.0K | $-2M | $-6M | $-1M | $3M | $1M | $173.0K | |
| Amort. of Intangibles | $14M | $16M | $15M | $15M | $17M | $14M | $11M | $11M | $5M | $4M | $2M | $2M | |
| Other Non-cash | $-17M | $-1M | $13M | $-20M | $-17M | $611.0K | $-11M | $-5M | $-8M | $-8M | · | $-9M | |
| Operating Cash Flow | $40M | $22M | $19M | $-5M | $-3M | $12M | $16M | $10M | $11M | $20M | $11M | $8M | |
| CapEx | $39M | $11M | $10M | $11M | $13M | $7M | $8M | $6M | $7M | $6M | $3M | $4M | |
| Investing Cash Flow | $-42M | $-28M | $-502.0K | $-11M | $6M | $-73M | $-24M | $-7M | $-171M | $-79M | $-4M | · | |
| Debt Issued | $0 | $184M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $-210.0K | $-28M | $-3M | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $13M | $6M | $4M | $3M | $4M | $2M | $5M | $4M | $3M | $2M | $2M | $3M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | $6M | |
| Net Stock Activity | $13M | $6M | $4M | $3M | $4M | $2M | $5M | $4M | $3M | $2M | · | $-3M | |
| Dividends Paid | · | · | · | · | · | · | · | · | · | · | $3M | $3M | |
| Financing Cash Flow | $11M | $2M | $865.0K | $-2M | $-12M | $94M | $-1M | $-3M | $143M | $73M | $-3M | · | |
| Net Change in Cash | $11M | $-5M | $20M | $-16M | $-7M | $28M | $-8M | $1M | $-17M | $14M | $4M | $-4M | |
| Taxes Paid | $3M | · | · | · | · | · | · | · | · | · | $145.0K | $3M | |
| Free Cash Flow | $839.0K | $11M | $11M | $-14M | $-16M | $5M | $8M | $4M | $4M | $14M | · | $4M | |
| Levered FCF | · | · | $-25M | $-38M | $-33M | $-11M | $-8M | $-3M | $-925.8K | $12M | · | · |
Lucratividade
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.4% | 64.0% | 64.7% | 64.5% | 66.1% | 66.3% | 66.3% | 65.8% | 67.8% | 65.9% | · | 63.1% | |
| Operating Margin | 7.6% | 10.0% | 1.6% | 2.0% | 2.7% | 0.96% | 6.2% | 3.5% | 4.2% | 12.1% | · | 6.1% | |
| Net Margin | 2.2% | -3.4% | -8.7% | -6.1% | -5.0% | -6.6% | 0.62% | -1.1% | 1.9% | 6.0% | · | 5.1% | |
| Pretax Margin | 3.4% | -1.9% | -6.1% | -4.8% | -5.0% | -6.8% | 0.60% | -2.4% | 1.9% | 10.2% | · | 6.0% | |
| EBITDA Margin | 12.7% | 16.2% | 8.1% | 9.1% | 10.7% | 9.1% | 12.8% | 10.4% | 9.3% | 16.7% | · | 10.3% | |
| ROA | 1.2% | -1.7% | -4.0% | -2.5% | -1.9% | -2.4% | 0.29% | -0.49% | 0.82% | 4.3% | · | 4.2% | |
| ROE | 2.2% | -4.6% | -11.1% | -7.1% | -4.9% | -5.1% | 0.61% | -1.0% | 1.5% | 5.9% | · | 5.0% | |
| ROIC | 3.4% | 11.7% | 1.4% | 1.3% | 1.3% | 0.38% | 3.6% | 0.84% | 1.7% | 4.5% | · | 5.0% |
Liquidez e Solvência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 4.3 | 4.9 | 5.0 | 5.5 | 3.9 | 4.1 | 5.2 | 4.2 | 4.9 | · | 5.1 | |
| Quick Ratio | 1.5 | 2.0 | 2.3 | 2.0 | 2.4 | 1.8 | 1.9 | 2.6 | 2.0 | 2.8 | · | 2.6 | |
| Debt / Equity | 0.5 | 1.1 | 1.1 | 1.1 | 1.0 | 0.9 | 0.8 | 0.8 | 0.8 | 0.3 | · | · | |
| LT Debt / Equity | 0.5 | 1.1 | 1.1 | 1.1 | 1.0 | 0.9 | 0.8 | 0.8 | 0.8 | 0.3 | · | · | |
| Interest Coverage | · | · | 0.2 | 0.3 | 0.5 | 0.1 | 1.1 | 0.6 | 1.6 | 7.3 | · | · |
Eficiência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.5 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.4 | 0.7 | · | 0.8 | |
| Inventory Turnover | 1.8 | 1.7 | 1.6 | 1.5 | 1.4 | 1.4 | 1.9 | 1.9 | 1.7 | 3.0 | · | 4.7 | |
| Receivables Turnover | 5.2 | 5.1 | 5.3 | 5.5 | 6.0 | 5.1 | 5.5 | 5.6 | 5.0 | 7.0 | · | 7.4 |
Por Ação
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $9.09 | $6.36 | $6.62 | $6.80 | $7.26 | $8.14 | $7.32 | $7.15 | $7.37 | $6.11 | · | $5.09 | |
| Revenue / Share | $9.36 | $9.32 | $8.69 | $7.84 | $7.67 | $6.69 | $7.30 | $7.22 | $5.55 | $5.50 | · | $5.11 | |
| Cash Flow / Share | $0.85 | $0.53 | $0.46 | $-0.13 | $-0.07 | $0.33 | $0.42 | $0.27 | $0.32 | $0.60 | · | $0.29 | |
| Cash / Share | $1.32 | $1.23 | $1.38 | $0.94 | $1.33 | $1.52 | $0.87 | $1.08 | $1.06 | $1.65 | · | $1.14 | |
| Dividend / Share | · | · | · | · | · | · | $0.00 | $0.00 | $0.00 | $0.00 | $0.12 | $0.12 | |
| Dividend Paid / Share | · | · | · | · | · | · | · | · | · | · | $0.12 | $0.12 | |
| EPS (TTM) | $0.21 | $-0.32 | $-0.75 | $-0.48 | $-0.38 | $-0.44 | $0.05 | $-0.08 | $0.11 | $0.32 | $0.14 | $0.25 |
Taxas de Crescimento
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 13.6% | 9.8% | 12.8% | 5.0% | 18.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.0% | 9.1% | 11.8% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.8% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM)
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $441M | $389M | $354M | $314M | $299M | $253M | $276M | $263M | $190M | $180M | $146M | $145M | |
| Net Income TTM | $10M | $-13M | $-31M | $-19M | $-15M | $-17M | $2M | $-3M | $4M | $11M | $4M | $7M | |
| Market Cap | $2.25B | $1.24B | $761M | $507M | $842M | $954M | $1.06B | $1.09B | $720M | $656M | · | $331M | |
| Enterprise Value | $2.40B | $1.50B | $1.01B | $776M | $1.10B | $1.18B | $1.24B | $1.27B | $899M | $670M | · | · | |
| P/E | 217.2 | -89.3 | -23.8 | -25.2 | -53.6 | -53.7 | 541.8 | -354.8 | 174.1 | 59.8 | 77.0 | 45.3 | |
| P/S | 5.1 | 3.2 | 2.2 | 1.6 | 2.8 | 3.8 | 3.8 | 4.2 | 3.8 | 3.6 | · | 2.3 | |
| P/B | 5.0 | 4.5 | 2.7 | 1.8 | 2.8 | 2.9 | 3.7 | 4.0 | 2.6 | 3.1 | · | 2.2 | |
| P / Tangible Book | 31.9 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 56.4 | 55.8 | 40.4 | -98.4 | -325.9 | 77.1 | 66.8 | 110.5 | 66.7 | 33.2 | · | 40.8 | |
| P / FCF | 2681.7 | 112.4 | 66.8 | -35.8 | -53.7 | 189.2 | 136.3 | 266.6 | 172.7 | 48.5 | · | 87.0 | |
| EV / EBITDA | 42.7 | 23.8 | 35.0 | 27.1 | 34.2 | 51.1 | 35.0 | 46.2 | 50.8 | 22.2 | · | · | |
| EV / FCF | 2860.7 | 136.0 | 88.6 | -54.7 | -70.0 | 234.9 | 159.8 | 309.4 | 215.6 | 49.6 | · | · | |
| EV / Revenue | 5.4 | 3.9 | 2.9 | 2.5 | 3.7 | 4.7 | 4.5 | 4.8 | 4.7 | 3.7 | · | · | |
| Dividend Yield | · | · | · | · | · | · | · | · | · | · | · | 0.99% | |
| Earnings Yield | 0.46% | -1.1% | -4.2% | -4.0% | -1.9% | -1.9% | 0.18% | -0.28% | 0.57% | 1.7% | 1.3% | 2.2% | |
| Payout Ratio | · | · | · | · | · | · | · | · | · | · | · | 45.0% | |
| Annual Payout | · | · | · | · | · | · | · | · | · | · | $3M | $3M |
Demonstração de Resultados
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $126M | $116M | $116M | $113M | $113M | $99M | $97M | $96M | $98M | $97M | $94M | $88M | $89M | $83M | $79M | $77M | |
| Cost of Revenue | $45M | $41M | $43M | $39M | $40M | $35M | $36M | $35M | $35M | $34M | $33M | $32M | $31M | $30M | $29M | $28M | |
| Gross Profit | $81M | $75M | $73M | $74M | $73M | $64M | $62M | $61M | $63M | $63M | $61M | $56M | $58M | $54M | $51M | $49M | |
| R&D Expense | $9M | $9M | $9M | $8M | $7M | $7M | $7M | $7M | $7M | $7M | $8M | $6M | $7M | $7M | $8M | $12M | |
| SG&A Expense | $80M | $61M | $57M | $57M | $58M | $55M | $51M | $50M | $49M | $31M | $50M | $51M | $57M | $50M | $38M | $41M | |
| Operating Expenses | $89M | $70M | $66M | $65M | $65M | $61M | $59M | $57M | $57M | $38M | $58M | $58M | $65M | $58M | $47M | $53M | |
| Operating Income | $-8M | $6M | $11M | $13M | $8M | $2M | $3M | $4M | $7M | $25M | $3M | $-1M | $8M | $-4M | $4M | $-4M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $8M | · | $7M | $6M | $6M | · | $5M | |
| Interest Income | $367.0K | $205.0K | $311.0K | $240.0K | $68.0K | $144.0K | $374.0K | $366.0K | $353.0K | $374.0K | $398.0K | $339.0K | $265.0K | $75.0K | $61.0K | $40.0K | |
| Other Non-op | $4M | $-286.0K | $1M | $399.0K | $5M | $3M | $-10M | $2M | $-983.0K | $-1M | $2M | $-2M | $-4M | $963.0K | $4M | $-4M | |
| Pretax Income | $-12M | $339.0K | $7M | $7M | $3M | $-2M | $-17M | $-1M | $-2M | $13M | $-591.0K | $-9M | $-3M | $-9M | $3M | $-13M | |
| Income Tax | $2M | $-1M | $4M | $554.0K | $2M | $-2M | $-119.0K | $1M | $-306.0K | $5M | $3M | $382.0K | $725.0K | $5M | $1M | $1M | |
| Net Income | $-14M | $1M | $2M | $7M | $1M | $-505.0K | $-16M | $-2M | $-2M | $8M | $-4M | $-10M | $-3M | $-14M | $2M | $-14M | |
| EPS (Basic) | $-0.28 | $0.03 | $0.06 | $0.14 | $0.03 | $-0.01 | $-0.40 | $-0.05 | $-0.05 | $0.18 | $-0.10 | $-0.24 | $-0.08 | $-0.33 | $0.05 | $-0.34 | |
| EPS (Diluted) | $-0.28 | $0.03 | $0.06 | $0.13 | $0.03 | $-0.01 | $-0.40 | $-0.05 | $-0.05 | $0.18 | $-0.10 | $-0.24 | $-0.08 | $-0.33 | $0.05 | $-0.34 | |
| Shares (Basic) | 48,541,000 | 48,074,000 | · | 47,233,000 | 44,296,000 | 42,232,000 | · | 41,844,000 | 41,683,000 | 41,290,000 | · | 40,881,000 | 40,755,000 | 40,432,000 | · | 40,115,000 | |
| Shares (Diluted) | 48,541,000 | 49,731,000 | · | 48,775,000 | 45,378,000 | 42,232,000 | · | 41,844,000 | 41,683,000 | 47,886,000 | · | 40,881,000 | 40,755,000 | 40,432,000 | · | 40,115,000 | |
| EBITDA | $-8M | $12M | · | $13M | $8M | $8M | · | $4M | $7M | $31M | · | $-1M | $8M | $2M | · | $-4M |
Balanço Patrimonial
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $77M | $56M | $65M | $73M | $53M | $38M | $53M | $56M | $55M | $51M | · | $53M | $49M | $31M | · | $38M | |
| Receivables | $98M | $92M | $90M | $88M | $91M | $88M | $79M | $76M | $74M | $74M | · | $64M | $65M | $63M | · | $57M | |
| Inventory | $103M | $98M | $92M | $91M | $87M | $82M | $80M | $84M | $81M | $82M | · | $79M | $78M | $76M | · | $73M | |
| Prepaid Expense | $27M | $45M | $43M | $22M | $25M | $20M | $19M | $19M | $20M | $17M | · | $17M | $19M | $20M | · | $17M | |
| Current Assets | $371M | $358M | $358M | $337M | $319M | $287M | $290M | $288M | $285M | $277M | · | $267M | $264M | $241M | · | $238M | |
| PP&E (Net) | $74M | $68M | $65M | $41M | $40M | $38M | $36M | $38M | $37M | $38M | · | $37M | $38M | $39M | · | $36M | |
| Goodwill | $350M | $252M | $254M | $254M | $254M | $245M | $241M | $249M | $244M | $245M | $247M | $243M | $246M | $246M | $244M | $235M | |
| Intangibles | $149M | $120M | $124M | $126M | $129M | $128M | $128M | $135M | $135M | $138M | · | $143M | $147M | $150M | · | $148M | |
| Other Non-current Assets | $15M | $16M | $15M | $29M | $27M | $25M | $24M | $21M | $14M | $13M | · | $8M | $8M | $8M | · | $7M | |
| Total Assets | $1.07B | $883M | $885M | $858M | $838M | $791M | $789M | $803M | $790M | $784M | · | $775M | $778M | $757M | · | $743M | |
| Accounts Payable | $21M | $18M | $16M | $16M | $19M | $12M | $18M | $11M | $12M | $10M | · | $11M | $10M | $9M | · | $11M | |
| Accrued Liabilities | $16M | $17M | $16M | $12M | $11M | $12M | $12M | $16M | $16M | $16M | · | $10M | $10M | $10M | · | $10M | |
| Current Liabilities | $107M | $93M | $102M | $86M | $67M | $52M | $67M | $153M | $51M | $46M | · | $55M | $56M | $44M | · | $46M | |
| Capital Leases | $36M | $34M | $34M | $38M | $39M | $39M | $40M | $41M | $42M | $43M | · | $43M | $40M | $41M | · | $41M | |
| Deferred Tax | $26M | $28M | $24M | $22M | $23M | $22M | $20M | $19M | $22M | $22M | · | $20M | $19M | $24M | · | $34M | |
| Other Non-current Liabilities | $9M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $8M | $8M | · | $8M | $7M | $7M | · | $7M | |
| Total Liabilities | $626M | $433M | $437M | $419M | $418M | $497M | $513M | $498M | $494M | $489M | · | $503M | $495M | $477M | · | $488M | |
| Long-term Debt | $363M | $215M | $215M | $215M | $216M | $315M | $314M | $314M | $314M | $313M | · | $307M | $308M | $308M | · | $308M | |
| Total Debt | $363M | $215M | · | $215M | $216M | $315M | · | $314M | $314M | $313M | · | $307M | $308M | $308M | · | $308M | |
| Common Stock | $502.0K | $500.0K | $493.0K | $488.0K | $486.0K | $442.0K | $434.0K | $434.0K | $433.0K | $432.0K | · | $425.0K | $424.0K | $424.0K | · | $418.0K | |
| Retained Earnings | $-64M | $-50M | $-51M | $-54M | $-60M | $-62M | $-61M | $-45M | $-42M | $-40M | · | $-44M | $-34M | $-31M | · | $-19M | |
| Treasury Stock | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | · | $15M | $15M | $15M | · | $15M | |
| AOCI | $-12M | $-12M | $-3M | $-2M | $-3M | $-19M | $-25M | $-10M | $-16M | $-14M | · | $-21M | $-16M | $-18M | · | $-45M | |
| Stockholders' Equity | $446M | $450M | $448M | $439M | $420M | $294M | $276M | $305M | $295M | $295M | $282M | $272M | $283M | $280M | $284M | $255M | |
| Liabilities + Equity | $1.07B | $883M | $885M | $858M | $838M | $791M | $789M | $803M | $790M | $784M | · | $775M | $778M | $757M | · | $743M | |
| Shares Outstanding | 50,179,000 | 49,983,000 | 49,330,000 | 48,862,000 | 48,592,000 | 44,190,000 | 43,432,000 | 43,392,000 | · | · | 42,569,000 | 42,537,000 | 42,443,000 | 42,366,000 | 41,830,000 | 41,816,000 |
Fluxo de Caixa
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $7M | $6M | $6M | $6M | $6M | $5M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $6M | |
| Stock-based Comp | $8M | $8M | $4M | $6M | $6M | $8M | $3M | $4M | $4M | $3M | $4M | $3M | $4M | $3M | $3M | $3M | |
| Deferred Tax | · | · | · | · | · | · | $3M | · | · | · | $6M | · | · | · | · | · | |
| Amort. of Intangibles | $4M | $4M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Other Non-cash | · | $-15M | · | · | · | $-30M | · | · | · | $-22M | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-1M | $1M | $20M | $22M | $15M | $-17M | $10M | $11M | $6M | $-5M | $11M | $7M | $7M | $-6M | $-217.0K | $4M | |
| CapEx | $11M | $8M | $28M | $5M | $3M | $4M | $1M | $4M | $3M | $4M | $3M | $3M | $3M | $3M | $4M | $3M | |
| Investing Cash Flow | $-129M | $-11M | $-31M | $-5M | $-3M | $-4M | $-11M | $-11M | $-3M | $-4M | $-3M | $-2M | $7M | $-3M | $-3M | $-3M | |
| Debt Issued | · | · | $0 | $0 | $0 | $0 | $-6M | $160M | $160M | $190M | $0 | $0 | $0 | $0 | · | · | |
| Net Debt Issued | · | $0 | · | · | · | $-66.0K | · | · | · | $-182M | · | · | · | · | · | · | |
| Stock Issued | $1M | $1M | $3M | $5M | $278.0K | $4M | $443.0K | $2M | $59.0K | $4M | $488.0K | $886.0K | $0 | $3M | $24.0K | $1M | |
| Net Stock Activity | · | $1M | · | · | · | $4M | · | · | · | $4M | · | · | · | $3M | · | · | |
| Financing Cash Flow | $152M | $463.0K | $2M | $2M | $3M | $4M | $174.0K | $1M | $-181.0K | $737.0K | $-2M | $-909.0K | $2M | $1M | $-859.0K | $252.0K | |
| Net Change in Cash | $22M | $-9M | $-9M | $20M | $16M | $-16M | $-3M | $1M | $4M | $-8M | $5M | $5M | $18M | $-9M | $2M | $-3M | |
| Free Cash Flow | · | $-7M | · | · | · | $-21M | · | · | · | $-9M | · | · | · | $-8M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-14M | · | · | · | $-18M | · | · |
Lucratividade
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.0% | 64.8% | · | 65.6% | 64.7% | 64.2% | · | 63.7% | 64.6% | 64.6% | · | 64.0% | 65.1% | 64.5% | · | 63.4% | |
| Operating Margin | -6.7% | 5.0% | · | 11.1% | 7.4% | 2.2% | · | 4.6% | 6.6% | 26.0% | · | -1.4% | 8.6% | -4.6% | · | -5.3% | |
| Net Margin | -10.7% | 1.2% | · | 5.7% | 1.2% | -0.51% | · | -2.4% | -2.2% | 7.7% | · | -11.2% | -3.8% | -16.3% | · | -17.8% | |
| Pretax Margin | -9.3% | 0.29% | · | 6.2% | 3.1% | -2.3% | · | -1.3% | -2.5% | 13.1% | · | -10.7% | -3.0% | -10.7% | · | -16.3% | |
| EBITDA Margin | -6.7% | 10.4% | · | 11.1% | 7.4% | 7.7% | · | 4.6% | 6.6% | 32.0% | · | -1.4% | 8.6% | 2.2% | · | -5.3% | |
| ROA | -1.4% | 0.17% | · | 0.78% | 0.17% | -0.06% | · | -0.29% | -0.27% | 0.98% | · | -1.3% | -0.44% | -1.8% | · | -1.8% | |
| ROE | -3.1% | 0.38% | · | 1.8% | 0.38% | -0.17% | · | -0.79% | -0.73% | 2.6% | · | -3.7% | -1.2% | -4.7% | · | -4.8% | |
| ROIC | -1.2% | 3.6% | · | 1.8% | 0.51% | 0.08% | · | 1.3% | 0.93% | 2.5% | · | -0.22% | 1.7% | -1.0% | · | -0.80% |
Liquidez e Solvência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 3.9 | · | 3.9 | 4.8 | 5.5 | · | 1.9 | 5.6 | 6.0 | · | 4.9 | 4.7 | 5.5 | · | 5.2 | |
| Quick Ratio | 1.6 | 1.6 | · | 1.9 | 2.2 | 2.4 | · | 0.9 | 2.5 | 2.7 | · | 2.1 | 2.0 | 2.1 | · | 2.1 | |
| Debt / Equity | 0.8 | 0.5 | · | 0.5 | 0.5 | 1.1 | · | 1.0 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.2 | |
| LT Debt / Equity | 0.8 | 0.5 | · | 0.5 | 0.5 | 1.1 | · | 0.7 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 3.2 | · | -0.2 | 1.2 | -0.6 | · | -0.9 |
Eficiência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.4 | 0.5 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Receivables Turnover | 1.3 | 1.3 | · | 1.4 | 1.4 | 1.2 | · | 1.4 | 1.4 | 1.4 | · | 1.4 | 1.5 | 1.4 | · | 1.4 |
Por Ação
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.88 | $9.01 | · | $8.98 | $8.64 | $6.66 | · | $7.02 | · | · | · | $6.39 | $6.66 | $6.61 | · | $6.10 | |
| Revenue / Share | $2.59 | $2.34 | · | $2.32 | $2.49 | $2.34 | · | $2.29 | $2.35 | $2.03 | · | $2.15 | $2.19 | $2.06 | · | $1.92 | |
| Cash Flow / Share | · | $0.02 | · | · | · | $-0.40 | · | · | · | $-0.11 | · | · | · | $-0.15 | · | · | |
| Cash / Share | $1.54 | $1.12 | · | $1.50 | $1.10 | $0.85 | · | $1.29 | · | · | · | $1.26 | $1.15 | $0.73 | · | $0.90 | |
| EPS (TTM) | $-0.06 | $0.25 | · | $-0.25 | $-0.43 | $-0.51 | · | $-0.02 | $-0.21 | $-0.24 | · | $-0.60 | $-0.70 | $-0.73 | · | $-1.03 |
Avaliação (TTM)
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $471M | $459M | · | $423M | $405M | $390M | · | $385M | $377M | $368M | · | $340M | $329M | $320M | · | $314M | |
| Net Income TTM | $-3M | $12M | · | $-9M | $-18M | $-21M | · | $-851.0K | $-8M | $-10M | · | $-25M | $-28M | $-29M | · | $-41M | |
| Market Cap | $1.13B | $1.83B | · | $2.07B | $1.51B | $1.09B | · | $1.16B | · | · | · | $645M | $730M | $555M | · | $579M | |
| Enterprise Value | $1.41B | $1.99B | · | $2.21B | $1.67B | $1.36B | · | $1.41B | · | · | · | $899M | $988M | $832M | · | $849M | |
| P/E | -374.5 | 146.5 | · | -169.4 | -72.3 | -48.2 | · | -1331.0 | -122.1 | -88.2 | · | -25.3 | -24.6 | -17.9 | · | -13.4 | |
| P/S | 2.4 | 4.0 | · | 4.9 | 3.7 | 2.8 | · | 3.0 | · | · | · | 1.9 | 2.2 | 1.7 | · | 1.8 | |
| P/B | 2.5 | 4.1 | · | 4.7 | 3.6 | 3.7 | · | 3.8 | · | · | · | 2.4 | 2.6 | 2.0 | · | 2.3 | |
| P / Tangible Book | · | 23.2 | · | 35.5 | 41.0 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | 1586.1 | · | · | · | -64.1 | · | · | · | · | · | · | · | -90.2 | · | · | |
| EV / Revenue | 3.0 | 4.3 | · | 5.2 | 4.1 | 3.5 | · | 3.7 | · | · | · | 2.6 | 3.0 | 2.6 | · | 2.7 | |
| Dividend Yield | 0.30% | 0.19% | · | 0.16% | 0.23% | 0.31% | · | 0.30% | · | · | · | 0.53% | 0.47% | 0.61% | · | 0.59% | |
| Earnings Yield | -0.27% | 0.68% | · | -0.59% | -1.4% | -2.1% | · | -0.08% | -0.82% | -1.1% | · | -4.0% | -4.1% | -5.6% | · | -7.4% | |
| Annual Payout | $3M | $3M | · | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M |
Período mais recente à esquerda · valores nulos mostrados como ·
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Receita | $441M | $389M | $354M | $314M | $299M |
| Margem Bruta % | 64.4% | 64.0% | 64.7% | 64.5% | 66.1% |
| Margem Operacional % | 7.6% | 10.0% | 1.6% | 2.0% | 2.7% |
| Lucro líquido | $10M | $-13M | $-31M | $-19M | $-15M |
| EPS Diluído | $0.21 | $-0.32 | $-0.75 | $-0.48 | $-0.38 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | 0.5 | 1.1 | 1.1 | 1.1 | 1.0 |
| Índice de liquidez corrente | 3.5 | 4.3 | 4.9 | 5.0 | 5.5 |
| Índice de Liquidez Seca | 1.5 | 2.0 | 2.3 | 2.0 | 2.4 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $839.0K | $11M | $11M | $-14M | $-16M |
Investidores institucionais (13F) 213 declarantes · $1.2B total · Em 30 de Setembro de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Detentores
213
Valor detido
$1.2B
Novas posições
34
Posições encerradas
65
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 34 (-7 vs trimestre anterior) | 65 (+29 vs trimestre anterior) | 81 (-12 vs trimestre anterior) | 56 (-7 vs trimestre anterior) | +2.0M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| BlackRock, Inc. | $149.965.153 | 6.674.017 | 12,78% | Ações |
| VANGUARD GROUP INC | $144.587.760 | 3.170.089 | 12,33% | Ações |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $71.566.000 | 3.184.974 | 6,10% | Ações |
| MORGAN STANLEY | $57.477.400 | 2.557.961 | 4,90% | Ações |
| Juniper Investment Company, LLC | $45.386.816 | 2.019.885 | 3,87% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $45.043.789 | 2.004.619 | 3,84% | Ações |
| FMR LLC | $44.119.203 | 1.963.471 | 3,76% | Ações |
| STATE STREET CORP | $41.750.406 | 1.858.051 | 3,56% | Ações |
| Ophir Asset Management Pty Ltd | $40.446.180 | 1.800.008 | 3,45% | Ações |
| PERCEPTIVE ADVISORS LLC | $39.036.906 | 1.737.290 | 3,33% | Ações |
| Conestoga Capital Advisors, LLC | $36.484.539 | 1.623.700 | 3,11% | Ações |
| WELLINGTON MANAGEMENT GROUP LLP | $28.318.470 | 1.260.279 | 2,41% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $25.043.403 | 1.114.297 | 2,13% | Ações |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $23.011.325 | 1.024.091 | 1,96% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $22.205.281 | 988.219 | 1,89% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $21.300.127 | 947.941 | 1,82% | Ações |
| CITADEL ADVISORS LLC | $18.596.037 | 827.594 | 1,59% | Ações |
| YARGER WEALTH STRATEGIES, LLC | $15.278.432 | 634.223 | 1,30% | Ações |
| ROYCE & ASSOCIATES LP | $14.364.667 | 639.282 | 1,22% | Ações |
| NORTHERN TRUST CORP | $12.370.454 | 550.532 | 1,05% | Ações |
| BANK OF AMERICA CORP /DE/ | $11.716.689 | 521.437 | 1,00% | Ações |
| Qube Research & Technologies Ltd | $10.704.820 | 476.405 | 0,91% | Ações |
| FRED ALGER MANAGEMENT, LLC | $10.406.104 | 463.111 | 0,89% | Ações |
| UBS Group AG | $10.210.390 | 454.401 | 0,87% | Ações |
| TWO SIGMA ADVISERS, LP | $9.974.907 | 218.700 | 0,85% | Ações |
| Invesco Ltd. | $9.956.839 | 443.117 | 0,85% | Ações |
| GOLDMAN SACHS GROUP INC | $9.857.903 | 438.714 | 0,84% | Ações |
| D. E. Shaw & Co., Inc. | $9.846.714 | 438.216 | 0,84% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $9.183.579 | 408.704 | 0,78% | Ações |
| Toroso Investments, LLC | $9.018.146 | 197.723 | 0,77% | Ações |
| Soleus Capital Management, L.P. | $8.718.360 | 388.000 | 0,74% | Ações |
| TWO SIGMA INVESTMENTS, LP | $8.702.159 | 387.279 | 0,74% | Ações |
| Balyasny Asset Management L.P. | $8.584.686 | 382.051 | 0,73% | Ações |
| First Eagle Investment Management, LLC | $7.787.496 | 346.573 | 0,66% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $6.978.103 | 310.552 | 0,59% | Ações |
| KENNEDY CAPITAL MANAGEMENT LLC | $6.611.371 | 294.231 | 0,56% | Ações |
| Legal & General Group Plc | $5.826.427 | 259.298 | 0,50% | Ações |
| WASATCH ADVISORS LP | $5.726.929 | 156.388 | 0,49% | Ações |
| PRINCIPAL FINANCIAL GROUP INC | $5.705.178 | 253.902 | 0,49% | Ações |
| Bank of New York Mellon Corp | $5.671.109 | 252.386 | 0,48% | Ações |
| Quantinno Capital Management LP | $4.497.191 | 200.142 | 0,38% | Ações |
| AMERIPRISE FINANCIAL INC | $4.348.978 | 193.546 | 0,37% | Ações |
| FIFTH THIRD BANCORP | $4.170.912 | 185.621 | 0,36% | Ações |
| ORBIMED ADVISORS LLC | $3.932.250 | 175.000 | 0,34% | Ações |
| Corient Private Wealth LP | $3.580.552 | 159.348 | 0,31% | Ações |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $3.324.253 | 90.777 | 0,28% | Ações |
| Public Sector Pension Investment Board | $3.298.304 | 146.787 | 0,28% | Ações |
| Parkman Healthcare Partners LLC | $3.121.982 | 138.940 | 0,27% | Ações |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $2.879.149 | 128.133 | 0,25% | Ações |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $2.857.263 | 127.159 | 0,24% | Ações |
Ativistas e proprietários de 5%+ 5 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Juniper Targeted Opportunity Fund, L.P., Juniper HF Investors II, LLC, Juniper Targeted Opportunities, L.P., Juniper Targeted Opportunity Investors, LLC, Juniper Multi-Strategy Fund, L.P., Juniper HF Investors, LLC, Juniper Investment Company, LLC, Alexis P. Michas, John A. Bartholdson ×2 declarações | 12 de Agosto de 2025 | 4,00% | Emenda | · | SEC |
| CryoLife, Inc., CL Falcon, Inc. | 11 de Maio de 2011 | · | Declaração inicial | M&A / venda | SEC |
| Michael A. Roth and Brian J. Stark, as joint filers pursuant to Rule 13d-1(k) | 10 de Julho de 2007 | · | Declaração inicial | · | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 2 de Dezembro de 2005 | · | Declaração inicial | Investimento passivo | SEC |
| Pessoa de relato não divulgada | 18 de Março de 2005 | · | Declaração inicial | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Executivos da empresa 49 insiders · 30 diretores · 15 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| James P Mackin | President & CEO | 19 de Agosto de 2026 S | 877.275 | 0 | 9 | $-9.722.946 |
| Lance A Berry | EVP, COO, CFO & Treasurer | 14 de Agosto de 2026 S | 210.112 | 0 | 5 | $-803.205 |
| David Ashley Lee | Executive VP, COO & CFO | 2 de Março de 2023 S | 347.217 | 0 | 0 | $0 |
| Andrew M Green | SVP, Regulatory and Quality | 10 de Setembro de 2026 S | 40.160 | 0 | 6 | $-1.431.215 |
| Jean F Holloway | SVP, General Counsel | 12 de Agosto de 2026 S | 184.118 | 0 | 13 | $-2.537.794 |
| Marshall S. Stanton | SVP, Clinical & MD Affair | 3 de Março de 2026 S | 60.097 | 0 | 13 | $-3.426.956 |
| John E Davis | Chief Commercial Officer | 3 de Março de 2026 S | 230.794 | 0 | 9 | $-1.745.924 |
| Amy Horton | VP, Chief Accounting Officer | 3 de Março de 2026 S | 139.088 | 0 | 8 | $-870.080 |
| Matthew A Getz | VP, Human Resources | 16 de Agosto de 2024 S | 34.116 | 0 | 0 | $0 |
| Florian Tyrs | VP, Global Operations | 27 de Fevereiro de 2024 S | 21.558 | 0 | 0 | $0 |
| Rochelle L. Maney | VP, Quality | 26 de Fevereiro de 2024 S | 44.518 | 0 | 0 | $0 |
| Robert C Thomson | VP Research & Development | 23 de Fevereiro de 2024 A | 13.291 | 0 | 0 | $0 |
| Dennis B Maier | SVP, Operations | 6 de Junho de 2023 S | 34.724 | 0 | 0 | $0 |
| Franz Peter Barthold | VP, Research & Development | 8 de Novembro de 2022 A | 32.516 | 0 | 0 | $0 |
| Scott B Capps | VP, Clinical Research | 12 de Março de 2021 F | 153.203 | 0 | 0 | $0 |
| James M Mcdermid | SVP, CHRO | 14 de Março de 2019 F | 30.806 | 0 | 0 | $0 |
| Sherry M Saurini | VP, Quality | 14 de Março de 2019 F | 25.084 | 0 | 0 | $0 |
| William Robert Matthews | Senior VP, Operations, Quality | 5 de Março de 2018 F | 39.883 | 0 | 0 | $0 |
| David C Gale | VP, Research & Development | 16 de Novembro de 2017 M | 77.135 | 0 | 0 | $0 |
| Steven G Anderson | Former Executive Chairman | 9 de Abril de 2015 F | 1.271.846 | 0 | 0 | $0 |
| Bruce G. Anderson | VP, US Sales &Global Marketing | 7 de Março de 2015 F | 42.106 | 0 | 0 | $0 |
| FRONK DAVID | VP, Regulatory Affairs | 7 de Março de 2015 F | 110.559 | 0 | 0 | $0 |
| David P. Lang | VP, Int'l Sales & Marketing | 26 de Fevereiro de 2015 A | 73.441 | 0 | 0 | $0 |
| Jeffrey W Burris | Vice President & Gen. Counsel | 15 de Agosto de 2014 M | 95.221 | 0 | 0 | $0 |
| Gerald B Seery | Sr. VP, Sales and Marketing | 30 de Novembro de 2012 S | 71.999 | 0 | 0 | $0 |
| Albert E Heacox | Sr. VP Research and Devl | 31 de Dezembro de 2011 F | 110.144 | 0 | 0 | $0 |
| Philip A Theodore | VP, General Counsel | 4 de Setembro de 2007 A | 23.100 | 0 | 0 | $0 |
| Sidney B Ashmore | Vice President of Marketing | 18 de Janeiro de 2006 M | 42.728 | 0 | 0 | $0 |
| Kirby S Black | Sr. Vice President, R&D | 21 de Setembro de 2004 M | 55.131 | 0 | 0 | $0 |
| Vander James C Wyk | VP - Product Integrity | 14 de Setembro de 2004 M | 36.165 | 0 | 0 | $0 |
| Anthony B. Semedo | Conselheiro | 2 de Junho de 2026 J | 6.325 | 0 | 0 | $0 |
| Elizabeth A Hoff | Conselheiro | 18 de Maio de 2026 A | 34.765 | 0 | 1 | $-189.420 |
| Marna P Borgstrom | Conselheiro | 18 de Maio de 2026 A | 56.664 | 0 | 0 | $0 |
| Jon W Salveson | Conselheiro | 18 de Maio de 2026 A | 137.416 | 0 | 0 | $0 |
| Jeffrey H Burbank | Conselheiro | 18 de Maio de 2026 A | 61.372 | 0 | 0 | $0 |
| Daniel J Bevevino | Conselheiro | 18 de Maio de 2026 A | 157.637 | 0 | 0 | $0 |
| Bullock James | Conselheiro | 18 de Maio de 2026 A | 76.223 | 0 | 0 | $0 |
| Thomas F Ackerman | Conselheiro | 18 de Maio de 2026 A | 157.472 | 0 | 0 | $0 |
| Harvey Morgan | Conselheiro | 30 de Agosto de 2021 G | 46.342 | 0 | 0 | $0 |
| Ronald D Mccall | Conselheiro | 25 de Agosto de 2021 S | 121.768 | 0 | 0 | $0 |
| Elkins C Ronald | Conselheiro | 5 de Setembro de 2018 S | 64.843 | 0 | 0 | $0 |
| James Benson | Conselheiro | 2 de Outubro de 2017 S | 54.086 | 0 | 0 | $0 |
| John M Cook | Conselheiro | 9 de Junho de 2009 M | 85.000 | 0 | 0 | $0 |
| LACY VIRGINIA C | Conselheiro | 24 de Abril de 2007 S | 255.280 | 0 | 0 | $0 |
| VAN DYNE BRUCE J MD | Conselheiro | 1 de Agosto de 2006 A | 12.800 | 0 | 0 | $0 |
| OSS CAPITAL MANAGEMENT | Detentor de 10% | 31 de Maio de 2007 S | 1.918.000 | 0 | 0 | $0 |
| Michael S Simpson | · | 5 de Março de 2021 F | 33.698 | 0 | 0 | $0 |
| Thomas J Bogenschuetz | · | 5 de Maio de 2020 A | 23.451 | 0 | 0 | $0 |
| Thomas J Lynch | · | 2 de Novembro de 2004 A | 5.000 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 36 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,64% | 42.246 NS | 31 de Julho de 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 0,60% | 46.980 SH | 1 de Outubro de 2026 | Diário |
| RZG · Invesco Exchange-Traded Fund Trust | 0,42% | 21.951 SH | 1 de Outubro de 2026 | Diário |
| EBIT · Harbor ETF Trust | 0,25% | 1.133 NS | 31 de Julho de 2026 | N-PORT |
| ESSC · Strategy Shares | 0,17% | 2.304 NS | 31 de Julho de 2026 | N-PORT |
| IHI · iShares Trust | 0,16% | 203.954 SH | 11 de Setembro de 2026 | Diário |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,10% | 50.848 SH | 19 de Agosto de 2026 | Diário |
| IWO · iShares Trust | 0,07% | 429.440 SH | 11 de Setembro de 2026 | Diário |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,06% | 49.054 SH | 19 de Agosto de 2026 | Diário |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,05% | 148.966 SH | 19 de Agosto de 2026 | Diário |
| RSSL · Global X Funds | 0,04% | 21.860 NS | 31 de Julho de 2026 | N-PORT |
| ISCG · iShares Trust | 0,04% | 14.453 SH | 11 de Setembro de 2026 | Diário |
| IWM · iShares Trust | 0,04% | 1.164.969 SH | 11 de Setembro de 2026 | Diário |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 263.046 SH | 19 de Agosto de 2026 | Diário |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,03% | 23.937 SH | 1 de Outubro de 2026 | Diário |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 30.932 SH | 30 de Setembro de 2026 | Diário |
| DFAS · Dimensional ETF Trust | 0,02% | 124.676 NS | 31 de Julho de 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 20.435 NS | 31 de Julho de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 495.296 SH | 19 de Agosto de 2026 | Diário |
| VHT · VANGUARD WORLD FUND | 0,01% | 127.662 SH | 19 de Agosto de 2026 | Diário |
| WSML · iShares Trust | 0,01% | 2.287 SH | 11 de Setembro de 2026 | Diário |
| DXUV · Dimensional ETF Trust | 0,01% | 1.400 NS | 31 de Julho de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 90.038 NS | 31 de Julho de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 3.634 NS | 31 de Julho de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 4.761 NS | 31 de Julho de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 9.530 NS | 31 de Julho de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 13.831 NS | 31 de Julho de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 61.878 SH | 11 de Setembro de 2026 | Diário |
| IWV · iShares Trust | 0,00% | 10.858 SH | 11 de Setembro de 2026 | Diário |
| DFAT · Dimensional ETF Trust | 0,00% | 2.692 NS | 31 de Julho de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.463.340 SH | 19 de Agosto de 2026 | Diário |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.652 SH | 19 de Agosto de 2026 | Diário |
| IJR · iShares Trust | · | 2.603.782 SH | 10 de Setembro de 2026 | Diário |
| IJT · iShares Trust | · | 403.685 SH | 9 de Setembro de 2026 | Diário |
| XJR · iShares Trust | · | 5.899 SH | 2 de Setembro de 2026 | Diário |
| ISCB · iShares Trust | · | 2.111 SH | 11 de Setembro de 2026 | Diário |
AORT Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
classificação · 14 analistas
COMPRA
Alvo mediano
$42.00
+88,3%
5 35,7%
Compra forte
8 57,1%
Compra
1 7,1%
Manter
0 0,0%
Venda
0 0,0%
Venda forte
Preço-alvo de 12 meses
8 analistas · 2026-09-29Alvo médio $42.15 +88,9%
← Abaixo de todos os alvos
Preço atual $22.31
Mín$38.00
Média$42.15
Máx$48.00
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| AORT | $2.25B | 217.2 | 13.6% | 2.2% | 2.2% | 64.4% |
| IRMD | $1.24B | 55.6 | 14.4% | 26.8% | 23.8% | 76.8% |
| IART | · | -1.8 | 1.5% | -31.6% | -49.6% | · |
| ENOV | $1.52B | -1.3 | 6.7% | -52.7% | -58.5% | 59.8% |
| BBNX | $1.35B | -16.8 | 53.9% | -73.0% | -24.9% | 55.4% |
| PRCT | $1.77B | -18.3 | 37.2% | -31.0% | -25.4% | 63.7% |
| CBLL | $822M | -15.0 | 36.1% | -60.0% | -32.6% | 87.9% |
| SIBN | $861M | -44.8 | 20.2% | -9.4% | -10.9% | 79.6% |
| VREX | $498M | -7.0 | 4.1% | -8.3% | -14.0% | 34.4% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Últimas notícias Notícias recentes mencionando esta empresa
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Fonte: SEC 10-Q arquivado Ago 7, 2026